Exagen (XGN) News Today $9.74 +0.19 (+1.99%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$9.74 -0.01 (-0.05%) As of 07:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Stonepine Capital Management LLC Sells 155,302 Shares of Exagen Inc. $XGNAugust 26 at 7:38 AM | marketbeat.comShort Interest in Exagen Inc. (NASDAQ:XGN) Expands By 52.8%August 20, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Buy" by BrokeragesAugust 18, 2025 | marketbeat.comExagen Inc. to Participate in Third Quarter Investor ConferencesAugust 6, 2025 | gurufocus.comExagen Inc. to Participate in Third Quarter Investor ConferencesAugust 6, 2025 | globenewswire.comExagen Inc. (NASDAQ:XGN) Short Interest Up 144.8% in JulyAugust 4, 2025 | marketbeat.comBTIG Sticks to Their Buy Rating for Exagen (XGN)August 2, 2025 | theglobeandmail.comFY2026 EPS Estimates for Exagen Cut by Cantor FitzgeraldAugust 2, 2025 | marketbeat.comWilliam Blair Has Negative Outlook of Exagen FY2025 EarningsAugust 2, 2025 | marketbeat.comWhat is KeyCorp's Forecast for Exagen Q3 Earnings?August 2, 2025 | marketbeat.comExagen (XGN) Receives a Buy from Craig-HallumAugust 1, 2025 | theglobeandmail.comFY2026 Earnings Forecast for Exagen Issued By KeyCorpAugust 1, 2025 | marketbeat.comExagen Inc. Reports Record Revenue Amidst Growth ChallengesAugust 1, 2025 | theglobeandmail.comCanaccord Genuity Sticks to Its Buy Rating for Exagen (XGN)July 31, 2025 | theglobeandmail.comExagen (NASDAQ:XGN) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysJuly 31, 2025 | marketbeat.comExagen (NASDAQ:XGN) Upgraded to "Overweight" at KeyCorpJuly 31, 2025 | marketbeat.comXGN | Exagen Inc. Annual Cash Flow Statement | MarketWatchJuly 31, 2025 | marketwatch.comKeybanc Upgrades Exagen (XGN)July 31, 2025 | msn.comExagen (NASDAQ:XGN) Posts Earnings Results, Hits EstimatesJuly 30, 2025 | marketbeat.comExagen upgraded to Overweight from Sector Weight at KeyBancJuly 30, 2025 | msn.comExagen Inc. (XGN) Q2 2025 Earnings Call TranscriptJuly 29, 2025 | seekingalpha.comExagen Inc. Reports Strong Q2 2025 ResultsJuly 29, 2025 | globenewswire.comCraig-Hallum Initiates Coverage of Exagen (XGN) with Buy RecommendationJuly 25, 2025 | msn.comExagen Inc. (XGN): A Bull Case TheoryJuly 24, 2025 | msn.comTD Cowen Remains a Buy on Exagen (XGN)July 23, 2025 | theglobeandmail.comExagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Buy" by AnalystsJuly 23, 2025 | marketbeat.comExagen (NASDAQ:XGN) Earns Buy Rating from Analysts at Craig HallumJuly 23, 2025 | marketbeat.comExagen (XGN) to Release Quarterly Earnings on TuesdayJuly 22, 2025 | marketbeat.comExagen Inc. Appoints Chas McKhann to Board of DirectorsJuly 17, 2025 | globenewswire.comExagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025July 15, 2025 | globenewswire.comExagen Insider Ups Holding During YearJune 29, 2025 | finance.yahoo.com2025-06-23 | Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics | NDAQ:XGN | Press Release - StockhouseJune 24, 2025 | stockhouse.comMichael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune DiagnosticsJune 23, 2025 | globenewswire.comExagen announces resale of up to 1.15M sharesJune 20, 2025 | msn.comCantor Fitzgerald Estimates Exagen FY2026 EarningsJune 13, 2025 | marketbeat.comExagen Inc. Holds 2025 Annual Stockholder MeetingJune 11, 2025 | tipranks.comToronto Dominion Bank Buys New Position in Exagen Inc. (NASDAQ:XGN)June 1, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Short Interest UpdateJune 1, 2025 | marketbeat.comToronto Dominion Bank Acquires New Holdings in Exagen Inc. (NASDAQ:XGN)May 25, 2025 | marketbeat.comStonepine Capital Management LLC Reduces Stock Holdings in Exagen Inc. (NASDAQ:XGN)May 20, 2025 | marketbeat.comResearch Analysts Issue Forecasts for Exagen FY2025 EarningsMay 20, 2025 | marketbeat.comCanaccord Genuity Group Issues Positive Forecast for Exagen (NASDAQ:XGN) Stock PriceMay 15, 2025 | marketbeat.comDriehaus Capital Management LLC Takes Position in Exagen Inc. (NASDAQ:XGN)May 12, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call TranscriptMay 11, 2025 | insidermonkey.comWilliam Blair Has Pessimistic Outlook of Exagen Q2 EarningsMay 10, 2025 | marketbeat.comExagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional SharesMay 9, 2025 | finance.yahoo.comExagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional SharesMay 9, 2025 | globenewswire.comWilliam Blair Forecasts Exagen's Q1 Earnings (NASDAQ:XGN)May 9, 2025 | marketbeat.comExagen Inc. Prices Public Offering of Common StockMay 8, 2025 | globenewswire.comKeyBanc maintains Exagen stock at Sector WeightMay 7, 2025 | investing.com Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XGN Media Mentions By Week XGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XGN News Sentiment▼1.771.03▲Average Medical News Sentiment XGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XGN Articles This Week▼22▲XGN Articles Average Week Get the Latest News and Ratings for XGN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Exagen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PNTG News FTRE News CDNA News FLGT News CSTL News AGL News INNV News TALK News AUNA News SBC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XGN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access